产品中心 抗体 其他一抗

所有图片(1/2)

SDHA Rabbit Polyclonal Antibody

Mitochondrial Succinate dehydrogenase [ubiquinone] flavoprotein subunit,Flavoprotein subunit of complex II (Fp),SDH2,SDHF

价格 400.00 供应商现货 : 3-5个工作日
货号 S0B0929
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    SDHA
  • 分子别名

    Mitochondrial Succinate dehydrogenase [ubiquinone] flavoprotein subunit, Flavoprotein subunit of complex II (Fp), Flavoprotein subunit of complex II (Fp), SDH2, SDHF
  • 免疫原

    Synthetic Peptide
  • Accession

    P31040
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Ms, Rt
  • 预测反应种属
    (反应种属缩写表)

    Xe, Or
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度
    WB 1:1000
背景介绍
  • SDHA, or succinate dehydrogenase subunit A, is a subunit of the mitochondrial enzyme complex II, which is part of the electron transport chain and the tricarboxylic acid (TCA) cycle. This enzyme complex is crucial for cellular respiration, and SDHA plays a key role in the conversion of succinate to fumarate while transferring electrons to ubiquinone. Mutations in the SDHA gene can lead to various types of tumors, including paragangliomas and pheochromocytomas, which are rare neuroendocrine tumors. These mutations may result in the accumulation of succinate, which can inhibit the enzyme's activity and lead to a pseudohypoxic state, contributing to tumorigenesis. SDHA-related tumors tend to be aggressive and have a high metastatic potential. They often require a multimodality treatment approach, including surgery, radiation therapy, and chemotherapy, and may respond poorly to traditional therapies. The diagnosis and monitoring of these tumors can be facilitated through biochemical markers and advanced imaging techniques such as PET/CT scans with specific radiotracers.

  • 免疫印迹

    • WB result of SDHA Rabbit pAb
      Primary antibody: SDHA Rabbit pAb at 1/1000 dilution
      Lane 1: HeLa whole cell lysate 20 µg
      Lane 2: HepG2 whole cell lysate 20 µg
      Lane 3: HT-1080 whole cell lysate 20 µg
      Lane 4: Jurkat whole cell lysate 20 µg
      Lane 5: MCF7 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 73 kDa
      Observed MW: 68 kDa

    • WB result of SDHA Rabbit pAb
      Primary antibody: SDHA Rabbit pAb at 1/1000 dilution
      Lane 1: RAW264.7 whole cell lysate 20 µg
      Lane 3: C2C12 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 73 kDa
      Observed MW: 68 kDa

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)